VBIO Valion Bio, Inc.
$0.78▼ -6.92%
Healthcare
Other
After hours
$0.80▲ +2.00%
Oct 27, 4:34 PM ET
Volume 316.2K
Avg Volume (10D) 3.23M
Key Metrics & Fundamentals
Market Cap
$1.64M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.68 - 70.00
% vs 50 MA
-67.41%
% vs 200 MA
-94.98%
RSI-14
22.6
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.33
Free Cash Flow
-$5.34M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.80M
COGS
–
Operating Exp
$6.42M
Operating Income
-$6.42M
EBIT
-$6.42M
Pretax Income
-$7.06M
Net Income
-$7.10M
EPS (Diluted)
-54.25
Price & Volume History
Loading chart…
Recent News
Valion Bio Receives Unsolicited Acquisition Interest in Velocity Bioworks; Weighs Strategic Options
ACCESS Newswire · Oct 26, 2026 8:00 AM ET
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
ACCESS Newswire · Oct 21, 2026 8:00 AM ET
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
ACCESS Newswire · Oct 15, 2026 8:00 AM ET
With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on Domestic CDMO Surge
ACCESS Newswire · Oct 14, 2026 8:15 AM ET
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
ACCESS Newswire · Oct 9, 2026 7:45 AM ET
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
ACCESS Newswire · Oct 5, 2026 8:30 AM ET
BC-Most Active Stocks
Associated Press · Sep 30, 2026 10:30 AM ET
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
ACCESS Newswire · Sep 30, 2026 7:45 AM ET
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
ACCESS Newswire · Sep 23, 2026 8:00 AM ET
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
ACCESS Newswire · Sep 22, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2025
See VBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.